Four Technical Domains Defining Surgical Autonomy

Autonomous robotic surgery encompasses computer-controlled, image-guided, and semi-autonomous systems capable of executing or assisting surgical tasks with reduced or no direct real-time human manipulation. A survey of 70+ patent and literature records spanning 2011 to 2026 reveals that the field resolves into four mechanistically distinct but frequently overlapping technical domains: autonomous or semi-autonomous motion control and navigation of robotic manipulators; image-guided and sensor-fused trajectory planning; tendon-driven and articulated instrument actuation; and collision avoidance and safety monitoring.

A consistent architectural motif across nearly all retrieved records is the master–slave or cooperative-control architecture, in which degrees of operator authority are progressively replaced by computational autonomy. This progression — from passive positioning assistance toward closed-loop autonomous execution — is the organising principle of the entire landscape. Systems range from vascular interventional robots that navigate blood-vessel lumens using intraoperative imaging to multi-robot controllers that autonomously revise surgical plans when one robot arm cannot reach its target.

From Kinematics to AI: The Innovation Timeline

The publication date range of retrieved records spans 2011 to 2026, with a clear four-phase clustering pattern that tracks the maturation of the field from foundational kinematic structures to AI-integrated autonomous execution.

The 2011–2017 foundational phase established the kinematic vocabulary: 6 DOF manipulators and remote-centre-of-motion (RCM) joints appear in records from Euratom/European Commission (2011) and Mirae Company (2012). Medical Microinstruments S.R.L. filed its foundational robotic set of surgery in Italy (2017), establishing the macro/micro-positioner cascade architecture that reappears across at least seven subsequent records. Samsung Electronics filed surgical robot control leveraging machine-learning movement prediction (Korea, 2014), an early signal of AI integration.

The 2018–2021 rapid scale-up phase shows the highest density of foundational filings in the dataset. Koninklijke Philips N.V. filed the first image-guided convergent ablation patent family (EP, 2018), Globus Medical began its large tracking-marker automation cluster (2020–2022), Covidien Limited Partnership filed multiple robotic assembly variants (2020–2022, JP), and Ethicon LLC established its robotic-assisted platform series.

The 2022–2024 commercialisation and AI integration phase introduced work-volume mapping for dynamic collision avoidance (Mazor Robotics, CN, 2024), coordinate alignment for robotic surgery (Biosense Webster, JP, 2024), and augmented reality navigation (Globus Medical, JP, 2023; Quantum Surgical, JP, 2025). These filings signal a transition from purely kinematic control toward perception-driven autonomy.

The 2025–2026 emerging frontier is represented by multi-arm telesurgical systems with remote surgeon consoles (SSI IP Holdings, JP, 2026), robotic spine systems incorporating AI feedback for access navigation (Relievant Medsystems, JP, 2026), and B. Braun’s dual-end-effector collaborative robot integrating visualization and instrument axes on one arm (DE/JP, 2024–2026).

“The dataset shows a clear shift from passive navigation assistance toward autonomous plan revision and motion execution — autonomy is the next regulatory frontier.”

Core Technology Clusters and Their Key Patents

Four distinct technology clusters emerge from the dataset, each addressing a different layer of the autonomous surgical stack — from perception and planning through to actuation and safety.

Cluster 1: Autonomous Navigation via Intraoperative Imaging

The most heavily represented technical cluster links intraoperative image acquisition — endoscopic, fluoroscopic, CT, or ultrasound — to autonomous or semi-autonomous motion commands, eliminating constant manual guidance. Controllers analyse image data in real time to generate navigation paths, compensate for patient motion such as respiration, and update surgical plans when obstructions are detected. According to WIPO, image-guided robotic systems represent one of the fastest-growing subfields within medical robotics patent activity globally.

Koninklijke Philips N.V.’s 2025 EP filing describes a controller that autonomously navigates multiple surgical robots relative to cardiac anatomy and revises the surgical plan in real time when a robot cannot follow the original trajectory. Beijing WeMed’s 2023 RU filing describes processor-driven intraoperative image analysis generating automatic navigation commands for intravascular catheter advancement, with manual override capability. Zeta Surgical’s 2024 JP filing uses image-based patient-movement tracking to trigger real-time robotic position adjustment and cooperative control state initiation.

Cluster 2: Tendon-Driven Articulated Instrument Control

A significant sub-domain, heavily populated by Medical Microinstruments Inc./S.p.A., covers the precision control of tendon-actuated end effectors — essential for microsurgery and tight anatomical spaces. Patents address elastoplastic tendon elongation compensation, calibration, motion scaling, and degree-of-freedom limiting to avoid operating-limit violations. Medical Microinstruments’ 2023 KR filing introduces a partial-autonomy mode in which only a subset of degrees of freedom follow the master device, enabling semi-autonomous assistance.

Cluster 3: Collision Avoidance and Workspace Safety

A dedicated cluster addresses the challenge of preventing unintended robot-arm collisions with patients, staff, and other arms — an essential safety prerequisite for autonomous operation. Approaches range from proximity-sensor-based prediction to torque-residual analysis enabling inter-arm collision detection without knowledge of relative arm positions. CMR Surgical’s 2023 JP filing describes residual torque analysis at each joint to determine inter-arm collision without requiring known relative positions. Mazor Robotics’ 2024 CN filing uses a machine-learning model to predict object motion during surgery and preemptively update robot navigation paths. Standards bodies including ISO have published frameworks (ISO 10218 and ISO/TS 15066) governing collaborative robot safety that will increasingly apply to surgical contexts.

Cluster 4: Preoperative Planning, Tracking, and AR/XR Integration

An increasingly prominent cluster integrates preoperative CT and imaging data, 3D anatomical models, and augmented or extended reality overlays to enable precise intraoperative guidance and semi-autonomous tool positioning. Globus Medical’s 2022 JP filing uses stereophotogrammetric infrared cameras to detect active and passive tracking markers, determining 3D positions of instruments and patients to enable automated trajectory execution. Quantum Surgical’s 2025 JP filing generates predictive models of marker motion across respiratory cycles and overlays 3D anatomical models in augmented reality to guide intervention timing. Research published via Nature has documented the clinical efficacy of AR-assisted surgical navigation, underscoring the translational relevance of this cluster.

Assignee Landscape: Who Holds the IP

The autonomous robotic surgery patent landscape in this dataset is moderately concentrated: three assignees — Koninklijke Philips N.V., Medical Microinstruments Inc./S.p.A., and Globus Medical Inc. — account for roughly one-third of all records. However, a long tail of specialised companies signals that the competitive perimeter is widening rapidly.

Japan is the dominant filing jurisdiction, with at least 40 of the retrievable patent records carrying JP jurisdiction. This strongly reflects PCT and US-origin families entering Japan, not necessarily Japanese-origin innovations. Korea accounts for approximately 10 records, mostly from Medical Microinstruments and a Beijing-based surgical technology company. Italy holds approximately 5 records, almost exclusively Medical Microinstruments S.p.A./S.r.l., indicating that this Italian company protects core IP domestically. Europe (EP) accounts for 2 records, both Philips convergent ablation filings from 2018 and 2025.

Only MicroPort (Shanghai) MedBot Co., Ltd. appears in this dataset as a Chinese OEM with direct product-company filings (2 JP records). Given China’s established surgical robotics manufacturing base, the absence of more China-origin filings likely reflects search-scope limitations rather than inactivity. The EPO‘s patent index confirms that China has become one of the fastest-growing filing jurisdictions for medical robotics globally, suggesting that dedicated CN-jurisdiction searches would reveal substantially more activity.

Five Emerging Directions in 2023–2026 Filings

Based on filings dated 2023–2026 in this dataset, five forward-looking directions are identifiable, each representing a departure from the kinematic and sensor-only paradigms that dominated earlier phases.

1. Predictive Collision Avoidance via Machine Learning

Mazor Robotics’ 2024 CN filing explicitly describes a machine-learning model that predicts object motion during surgery and preemptively updates the robot’s navigation path — a departure from reactive, sensor-only collision responses. This represents a qualitative shift: the robot anticipates rather than reacts, which is a prerequisite for higher levels of autonomous operation.

2. Biomechanical-Model-Driven Autonomous Targeting

Quantum Surgical’s 2025 JP filing uses a stored biomechanical model of the human body combined with real-time image capture to compute position and orientation setpoints autonomously, compensating for organ motion without explicit user input. This closes the loop between anatomical knowledge and real-time execution in a way that purely image-driven systems cannot achieve alone.

3. Respiratory-Cycle-Synchronized Intervention

Quantum Surgical’s augmented reality navigation system (JP, 2025) generates predictive models of respiratory marker motion to identify the optimal moment for robotic intervention — a critical enabler for autonomous hepatic, renal, or pulmonary procedures where organ displacement during breathing can exceed several centimetres.

4. Dual-End-Effector Collaborative Robots

B. Braun New Ventures GmbH’s records (DE, 2024; JP, 2026) describe a single robot arm carrying both a visualization unit and a surgical instrument, with a control unit autonomously managing their spatial relationship. This compresses system footprint while maintaining dual functionality — a meaningful advantage in space-constrained operating environments.

5. Networked Multi-Arm Telesurgical Platforms

SSI IP Holdings Inc.’s 2026 JP filings describe preoperative planning systems and multi-arm remote surgery platforms that link local and remote surgeon consoles over private networks. This points toward autonomous execution of pre-planned tasks at remote sites — a vector that will require IP coverage spanning communication protocols, latency compensation, and remote authority hand-off.

“SSI IP Holdings’ 2026 multi-arm remote surgery system and Beijing WeMed’s vascular navigation platform converge on a future where surgical robots execute plans transmitted from geographically remote experts.”

Strategic Implications for IP and R&D Teams

The dataset reveals several actionable strategic signals for IP professionals, R&D leaders, and patent counsel operating in or adjacent to the surgical robotics space.

Autonomy is the next regulatory frontier. The dataset shows a clear shift from passive navigation assistance toward autonomous plan revision and motion execution, as demonstrated by Philips, Quantum Surgical, and Mazor. IP strategists should map their portfolios against the autonomy spectrum — assistance, guidance, supervised autonomy, conditional autonomy — as regulatory classification by bodies such as the FDA will follow the same axis.

Tendon-drive precision is an underserved but protectable moat. Medical Microinstruments’ dense cluster of Korea and Italy filings around tendon elongation compensation, calibration, and degree-of-freedom limiting covers a narrow but critical mechanical sub-problem. Competitors entering microsurgery must navigate or design around this IP concentration.

Tracking infrastructure is becoming a platform layer. Globus Medical’s large tracking-marker automation family (7+ JP filings) and Zeta Surgical’s image-based cooperative control suggest that intraoperative tracking is transitioning from a peripheral accessory to a core autonomous control substrate. R&D teams should treat tracking modality — optical, electromagnetic, or image-based — as an architectural decision with a long IP tail.

Chinese OEM activity is nascent but signalled. Only MicroPort (Shanghai) MedBot and Mazor’s CN filing appear as CN-linked records in this dataset. Given China’s established surgical robotics manufacturing base, IP strategists should conduct dedicated CN-jurisdiction searches to obtain a complete picture of activity from companies such as Tinavi and MicroPort.

Telesurgery and remote autonomy represent the highest-growth vector. SSI IP Holdings’ 2026 multi-arm remote surgery system and Beijing WeMed’s vascular navigation platform converge on a future where surgical robots execute plans transmitted from geographically remote experts. This vector will require IP coverage spanning communication protocols, latency compensation, and remote authority hand-off — areas not yet densely covered in this dataset. PatSnap’s IP intelligence platform and R&D intelligence tools are designed to support exactly this kind of cross-domain landscape analysis.